Main Logo
Menu
About Us
Our Philosophy
The Industry and Us
Our Strategy
Our Technology
Key Applications
Clinical Programs
Preclinical Programs
Pipeline
Our Partnerships
Our Team
Executive Management
Board of Directors
Clinical Advisory Board
Media / Science Center
Contact Us
Investors
All SEC Filings
Investors
Investors
Overview
News
Press Releases
Email Alerts
In The News
Videos
Events & Presentations
Events
Presentations
Financial Info
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
Filings & Financials
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Management Team
Investor Resources
Contacts
Email Alerts
FAQs
Investor Fact Sheet
Filing Type:
View All
10-K
10-K/A
10-Q
3
4
424B3
424B4
424B5
424B8
425
8-A12B
8-A12G
8-A12G/A
8-K
8-K/A
ARS
AW
CERTNAS
CORRESP
D
DEF 14A
DEFA14A
DEL AM
DRS
EFFECT
NT 10-Q
POS AM
POS EX
PRE 14A
PREM14A
PRER14A
RW
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SEC STAFF LETTER
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
Date
Form
Description
PDF
XBRL
Pages
12/19/22
S-3
Registration statement for specified transactions by certain issuers
Documents
expand_more
EX-5.1
EX-23.1
EX-FILING FEES
17
12/16/22
8-K
Current report filing
2
12/16/22
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
12/09/22
424B4
Prospectus filed pursuant to Rule 424(b)(4)
99
12/08/22
POS EX
Post-effective amendment filed solely to add exhibits to a registration statement
Documents
expand_more
EX-4.10
EX-4.11
18
12/08/22
8-K
Current report filing
Documents
expand_more
EX-1.1
EX-99.1
16
12/06/22
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
12/06/22
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
12/06/22
EFFECT
Notice of Effectiveness
1
12/05/22
S-1/A
General form of registration statement for all companies including face-amount certificate companies
Documents
expand_more
EX-23.2
107
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
…
Page
8
Page
9
Page
10
Page
11
Page
12
Page
13
Page
14
Page
15
Page
16
Page
17
…
Page
47
Next Page
arrow_forward
Email Alerts
Company Profile
Contacts
RSS News Feed